Literature DB >> 27271800

A proton therapy system in Nagoya Proton Therapy Center.

Toshiyuki Toshito1,2, Chihiro Omachi3,4, Yoshiaki Kibe3,4, Hiroyuki Sugai3,4, Kensuke Hayashi3, Hiroki Shibata3, Keisuke Yasui3, Kenichiro Tanaka3, Takahiro Yamamoto3, Atsushi Yoshida3, Eiki Nikawa3, Kumiko Asai3, Akira Shimomura3, Ikuyo Okumura3, Toshinori Suzuki3, Hideto Kinou3, Shigeru Isoyama3, Hiroyuki Ogino3, Hiromitsu Iwata3, Yuta Shibamoto4, Jun'etsu Mizoe3.   

Abstract

The purpose of this paper is to describe an outline of a proton therapy system in Nagoya Proton Therapy Center (NPTC). The NPTC has a synchrotron with a linac injector and three treatment rooms: two rooms are equipped with a gantry and the other one is equipped with a fixed horizontal beamline. One gantry treatment room has a pencil beam scanning treatment delivery nozzle. The other two treatment rooms have a passive scattering treatment delivery nozzle. In the scanning treatment delivery nozzle, an energy absorber and an aperture system to treat head and neck cancer have been equipped. In the passive treatment delivery nozzle, a multi-leaf collimator is equipped. We employ respiratory gating to treat lung and liver cancers for passive irradiation. The proton therapy system passed all acceptance tests. The first patient was treated on February 25, 2013, using passive scattering fixed beams. Respiratory gating is commonly used to treat lung and liver cancers in the passive scattering system. The MLCs are our first choice to limit the irradiation field. The use of the aperture for scanning irradiation reduced the lateral fall off by half or less. The energy absorber and aperture system in scanning delivery is beneficial to treat head and neck cancer.

Entities:  

Keywords:  Proton therapy; Proton therapy facilities; Proton therapy physics; Proton therapy technology

Mesh:

Year:  2016        PMID: 27271800     DOI: 10.1007/s13246-016-0456-8

Source DB:  PubMed          Journal:  Australas Phys Eng Sci Med        ISSN: 0158-9938            Impact factor:   1.430


  13 in total

1.  Dosimetric effects of quality assurance-related setup errors in passive proton therapy for prostate cancer with and without a hydrogel spacer.

Authors:  Yuta Omi; Keisuke Yasui; Akira Shimomura; Rie Muramatsu; Hiromitsu Iwata; Hiroyuki Ogino; Akari Furukawa; Naoki Hayashi
Journal:  Radiol Phys Technol       Date:  2021-07-27

2.  Combined effects of cisplatin and photon or proton irradiation in cultured cells: radiosensitization, patterns of cell death and cell cycle distribution.

Authors:  Hiromitsu Iwata; Tsuyoshi Shuto; Shunsuke Kamei; Kohei Omachi; Masataka Moriuchi; Chihiro Omachi; Toshiyuki Toshito; Shingo Hashimoto; Koichiro Nakajima; Chikao Sugie; Hiroyuki Ogino; Hirofumi Kai; Yuta Shibamoto
Journal:  J Radiat Res       Date:  2020-11-16       Impact factor: 2.724

3.  Transient increases in serum α fetoprotein and protein induced by vitamin K antagonist II levels following proton therapy does not necessarily indicate progression of hepatocellular carcinoma.

Authors:  Maiko Yoshida; Hiroyuki Ogino; Hiromitsu Iwata; Yukiko Hattori; Shingo Hashimoto; Koichiro Nakajima; Shigeru Sasaki; Masaki Hara; Yoshitaka Sekido; Jun-Etsu Mizoe; Yuta Shibamoto
Journal:  Oncol Lett       Date:  2019-01-11       Impact factor: 2.967

4.  Acute toxicity of image-guided hypofractionated proton therapy for localized prostate cancer.

Authors:  Koichiro Nakajima; Hiromitsu Iwata; Hiroyuki Ogino; Yukiko Hattori; Shingo Hashimoto; Mikiko Nakanishi; Toshiyuki Toshito; Yukihiro Umemoto; Shoichiro Iwatsuki; Yuta Shibamoto; Jun-Etsu Mizoe
Journal:  Int J Clin Oncol       Date:  2017-11-02       Impact factor: 3.402

5.  Evaluation of dosimetric advantages of using patient-specific aperture system with intensity-modulated proton therapy for the shallow depth tumor.

Authors:  Keisuke Yasui; Toshiyuki Toshito; Chihiro Omachi; Kensuke Hayashi; Kenichiro Tanaka; Kumiko Asai; Akira Shimomura; Rie Muramatsu; Naoki Hayashi
Journal:  J Appl Clin Med Phys       Date:  2017-11-27       Impact factor: 2.102

6.  Proton therapy for non-squamous cell carcinoma of the head and neck: planning comparison and toxicity.

Authors:  Hiromitsu Iwata; Toshiyuki Toshito; Kensuke Hayashi; Maho Yamada; Chihiro Omachi; Koichiro Nakajima; Yukiko Hattori; Shingo Hashimoto; Yo Kuroda; Yoshihide Okumura; Jun-Etsu Mizoe; Hiroyuki Ogino; Yuta Shibamoto
Journal:  J Radiat Res       Date:  2019-10-23       Impact factor: 2.724

7.  Changes in sexual function and serum testosterone levels in patients with prostate cancer after image-guided proton therapy.

Authors:  Yukiko Hattori; Hiromitsu Iwata; Koichiro Nakajima; Kento Nomura; Kensuke Hayashi; Toshiyuki Toshito; Shingo Hashimoto; Yukihiro Umemoto; Jun-Etsu Mizoe; Hiroyuki Ogino; Yuta Shibamoto
Journal:  J Radiat Res       Date:  2021-05-12       Impact factor: 2.724

8.  Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer.

Authors:  Koichiro Nakajima; Hiromitsu Iwata; Hiroyuki Ogino; Yukiko Hattori; Shingo Hashimoto; Toshiyuki Toshito; Kensuke Hayashi; Kenji Akita; Fumiya Baba; Katsumi Nakamae; Jun-Etsu Mizoe; Yuta Shibamoto
Journal:  Radiat Oncol       Date:  2018-10-11       Impact factor: 3.481

9.  In silico comparison of the dosimetric impacts of a greater omentum spacer for abdominal and pelvic tumors in carbon-ion, proton and photon radiotherapy.

Authors:  Masayoshi Yamada; Hiraku Sato; Yoshiro Ieko; Yuya Miyasaka; Takayuki Kanai; Natsuko Yano; Takashi Ono; Hiroko Akamatsu; Mayumi Harada; Mayumi Ichikawa; Yasushi Teranishi; Yasuhiro Kikuchi; Kenji Nemoto
Journal:  Radiat Oncol       Date:  2019-11-21       Impact factor: 3.481

10.  Spot Scanning Proton Therapy for Sinonasal Malignant Tumors.

Authors:  Koichiro Nakajima; Hiromitsu Iwata; Yukiko Hattori; Kento Nomura; Shingo Hashimoto; Toshiyuki Toshito; Kensuke Hayashi; Yo Kuroda; Hideo Fukano; Hiroyuki Ogino; Yuta Shibamoto
Journal:  Int J Part Ther       Date:  2021-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.